Not applicableActive Not RecruitingNCT07389642What this trial is testingBrain Oligometastasis in NSCLCWho this might be right forBrain OligometastaticNon-small Cell Lung Cancer University Hospital, Bordeaux 46
Testing effectiveness (Phase 2)Study completedNCT04181788What this trial is testingSasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced MalignanciesWho this might be right forAdvanced MalignanciesNon-small-cell Lung Cancer Pfizer 155
Testing effectiveness (Phase 2)Ended earlyNCT04372927What this trial is testingADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-ImmunotherapyWho this might be right forLocally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+2 more University of Washington 1
Early research (Phase 1)Study completedNCT02166242What this trial is testingEthaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung CancersWho this might be right forCarcinoma, Non-small Cell Lung Hunan Province Tumor Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT02382406What this trial is testingCarboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLCWho this might be right forNon-Small Cell Lung Cancer Nisha Mohindra, MD 46
Large-scale testing (Phase 3)Active Not RecruitingNCT04547504What this trial is testingPEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %Who this might be right forNon-small-cell Lung Cancer University Hospital, Brest 349
Early research (Phase 1)Looking for participantsNCT06066138What this trial is testingTherapeutic Drug Monitoring-Based Atezolizumab DosingWho this might be right forLocally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more National Cancer Institute (NCI) 30
Not applicableUnknownNCT00503958What this trial is testingLiverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung CancerWho this might be right forHealth Status UnknownLung Cancer University of Liverpool Cancer Research Centre 8,300
Testing effectiveness (Phase 2)Study completedNCT01858389What this trial is testingDacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Pfizer 41
Testing effectiveness (Phase 2)UnknownNCT05603013What this trial is testingVinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)Who this might be right forCarcinoma, Non-Small-Cell LungCarcinoma Breast Second Affiliated Hospital of Soochow University 45
Not applicableActive Not RecruitingNCT02515760What this trial is testingTumor-specific T Cells in Lung CancerWho this might be right forNon-small Cell Lung Cancer University Hospital Heidelberg 120
Not applicableStudy completedNCT03926260What this trial is testingEarly Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNAWho this might be right forMetastatic Non-small Cell Lung Cancer Centre Hospitalier Departemental Vendee 100
Not applicableStudy completedNCT03643484What this trial is testingIMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation TherapyWho this might be right forCarcinoma, Non-Small-Cell Lung AstraZeneca 634
Testing effectiveness (Phase 2)Looking for participantsNCT05613452What this trial is testingCarbon Ion Therapy for Peripheral Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Shanghai Proton and Heavy Ion Center 43
Early research (Phase 1)Study completedNCT02197247What this trial is testingStudy to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLCWho this might be right forNon Small Cell Lung Cancer AstraZeneca 41
Testing effectiveness (Phase 2)Looking for participantsNCT06109558What this trial is testingThe Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLCWho this might be right forNon Small Cell Lung CancerRET Gene MutationMET Amplification+1 more Hunan Province Tumor Hospital 120
Large-scale testing (Phase 3)Study completedNCT00622349What this trial is testingRandomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung European Lung Cancer Working Party 707
Testing effectiveness (Phase 2)Study completedNCT00089726What this trial is testingA Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)Who this might be right forLung CancerCarcinoma, Non-Small-Cell Lung Cell Genesys 100
Not applicableUnknownNCT04984148What this trial is testingConstruction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLCWho this might be right forStage III Non-small Cell Lung Cancer Guangdong Provincial People's Hospital 70
Large-scale testing (Phase 3)UnknownNCT03402048What this trial is testingThe EPIC Trial The Elderly Patient Individualized Chemotherapy TrialWho this might be right forStage IV, NSCLCLung NeoplasmsBronchial Neoplasms+6 more University of Turin, Italy 567